Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Lanzillo

Showing results (51-60 of 210) with videos related to

Pageof 21
Sort By:
Multiple Sclerosis and Related Disorders|November 24, 2019
The impact of diagnostic criteria and treatments on the 20-year costs for treating relapsing-remitting multiple sclerosisMartina Petruzzo, Raffaele Palladino, Antonio Nardone, et al.
Radiology|February 24, 2012
Multiple sclerosis: cerebral circulation timeMarcello Mancini, Vincenzo Brescia Morra, Orlando Di Donato, et al.
Journal of Neurology|April 17, 2024
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implicationsAntonio Luca Spiezia, Giulia Scalia, Maria Petracca, et al.
International Neurourology Journal|May 6, 2021
Interplay Between Cognitive and Bowel/Bladder Function in Multiple SclerosisAntonio Carotenuto, Teresa Costabile, Marcello Moccia, et al.
Open Forum Infectious Diseases|November 15, 2019
Incidence and Predictive Risk Factors of Infective Events in Patients With Multiple Sclerosis Treated With Agents Targeting CD20 and CD52 Surface AntigensEmanuela Zappulo, Antonio Riccardo Buonomo, Francesco Saccà, et al.
Frontiers in Neurology|December 26, 2022
Determinants of early working impairments in multiple sclerosisMarcello Moccia, Luca Fontana, Raffaele Palladino, et al.
Journal of Biomedical Optics|August 9, 2020
Surface-enhanced Raman spectroscopy of tears: toward a diagnostic tool for neurodegenerative disease identificationGilda Cennamo, Daniela Montorio, Vincenzo Brescia Morra, et al.
Journal of Neurology|August 11, 2022
Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of ItalyMarcello Moccia, Giuseppina Affinito, Giulia Berera, et al.
Clinical Neurology and Neurosurgery|June 22, 2024
Tango classes in people with Multiple Sclerosis (PwMS): Impact on motor and non-motor functionsAssunta Trinchillo, Daniele Caliendo, Valerio Nicolella, et al.
Clinical Chemistry and Laboratory Medicine|September 23, 2014
Uric acid: a potential biomarker of multiple sclerosis and of its disabilityMarcello Moccia, Roberta Lanzillo, Raffaele Palladino, et al.
Pageof 21

Showing results (51-60 of 210) with videos related to

Sort By:
Pageof 21
Multiple Sclerosis and Related Disorders|November 24, 2019
The impact of diagnostic criteria and treatments on the 20-year costs for treating relapsing-remitting multiple sclerosisMartina Petruzzo, Raffaele Palladino, Antonio Nardone, et al.
Radiology|February 24, 2012
Multiple sclerosis: cerebral circulation timeMarcello Mancini, Vincenzo Brescia Morra, Orlando Di Donato, et al.
Journal of Neurology|April 17, 2024
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implicationsAntonio Luca Spiezia, Giulia Scalia, Maria Petracca, et al.
International Neurourology Journal|May 6, 2021
Interplay Between Cognitive and Bowel/Bladder Function in Multiple SclerosisAntonio Carotenuto, Teresa Costabile, Marcello Moccia, et al.
Open Forum Infectious Diseases|November 15, 2019
Incidence and Predictive Risk Factors of Infective Events in Patients With Multiple Sclerosis Treated With Agents Targeting CD20 and CD52 Surface AntigensEmanuela Zappulo, Antonio Riccardo Buonomo, Francesco Saccà, et al.
Frontiers in Neurology|December 26, 2022
Determinants of early working impairments in multiple sclerosisMarcello Moccia, Luca Fontana, Raffaele Palladino, et al.
Journal of Biomedical Optics|August 9, 2020
Surface-enhanced Raman spectroscopy of tears: toward a diagnostic tool for neurodegenerative disease identificationGilda Cennamo, Daniela Montorio, Vincenzo Brescia Morra, et al.
Journal of Neurology|August 11, 2022
Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of ItalyMarcello Moccia, Giuseppina Affinito, Giulia Berera, et al.
Clinical Neurology and Neurosurgery|June 22, 2024
Tango classes in people with Multiple Sclerosis (PwMS): Impact on motor and non-motor functionsAssunta Trinchillo, Daniele Caliendo, Valerio Nicolella, et al.
Clinical Chemistry and Laboratory Medicine|September 23, 2014
Uric acid: a potential biomarker of multiple sclerosis and of its disabilityMarcello Moccia, Roberta Lanzillo, Raffaele Palladino, et al.
Pageof 21